AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Oncology Research Article
PDF (307.6 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Retraction | Open Access

Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2

References

【1】
【1】
 
 
Crossref Google Scholar
Oncology Research
Volume 34 Issue 5,
April 2026
Article number: 40
DOI: 10.32604/or.2026.081624

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Retraction: miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2. Oncology Research, 2026, 34(5): 40. https://doi.org/10.32604/or.2026.081624

4

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus
Published: 22 April 2026
© The Author 2026.

This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.